|
|
||||||||
From the Department of Obstetrics and Gynccology at the Academish Ziekenhuis Universiteit Rotterdam, The Netherlands
The efficacy of miconazole and nystatin in the treatment of vulvovaginal candidosis was compared in a multiccnter trial involving 9-1 pregnant patients. All patients had subjective complaints and were mycologically positive. Miconazole 2% vaginal cream was applied once daily for at least 10 days by 45 patients, whereas the 49 others received nystatin tablets for intravaginal application during 7 to 9 days. At the first examination following treatment, the cure rate with miconazole was 83% and with nystatin 68%. Follow-up examinations revealed a significantly lower recurrence rate in the miconazolc-trcatcd group. No important adverse experiences were noted.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |